Saturday 10 October 2026 Export all CMPS data to Excel Powerpack

COMPASS Pathways PLC Sponsored ADR

In the quarter to June 2026, EPS fell 358.5%, free cash flow fell 4.18% and total debt rose 64.0%, each against the same quarter a year earlier.

12.00 0.53 +4.62%

Follow CMPS

Alert me

Market cap: $1.6B
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 1,590.00

Revenue —

Net Income (394.19)

Free Cash Flow (161.14)

Net Debt (382.99)

Current Ratio 1.30

Debt/Equity 0.60

P/E ratio 0.00

Fwd P/E —

P/S ratio 0.00

P/B ratio 19.17

Past 5Y EPS Growth —

This Y EPS Growth 26.83%

Next Y EPS Growth 26.18%

Next Y revenue growth —

Next 5Y EPS Growth 27.55%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/B against its own 10 years 96.28%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	221	165	150	434
Receivables	—	—	—	—
Inventory	—	—	—	—
Other	—	—	—	—
	261	201	191	476

	2023	2024	2025	Q'26
Payables	6	12	15	12
ST’ Debt	—	6	18	—
Other	—	—	204	337
	20	34	248	367

Compound Annual Growth %

	10y	5y	3y
Sales	—	—	—
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	0.00%

Revenue $m

	Year

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(48)	(40)	—	—	—
’25	(46)	(39)	(35)	(38)	(157)
’24	(21)	(34)	(22)	(42)	(119)
’23	(28)	(25)	(17)	(28)	(97)
’22	(23)	(18)	(19)	(45)	(105)
’21	(14)	(18)	(14)	(22)	(68)
’20	(4)	(6)	(14)	(17)	(41)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(48)	(40)	—	—	—
’25	(46)	(39)	(35)	(38)	(157)
’24	(21)	(34)	(22)	(42)	(119)
’23	(28)	(25)	(17)	(28)	(97)
’22	(23)	(18)	(19)	(45)	(106)
’21	(14)	(18)	(14)	(22)	(68)
’20	(5)	(6)	(14)	(17)	(42)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.30)	(1.88)	—	—	—
’25	(0.18)	(0.41)	(1.44)	(1.00)	(3.08)
’24	(0.55)	(0.56)	(0.56)	(0.63)	(2.30)
’23	(0.57)	(0.62)	(0.67)	(0.53)	(2.32)
’22	(0.50)	(0.50)	(0.43)	(0.73)	(2.16)
’21	(0.35)	(0.44)	(0.38)	(0.61)	(1.79)
’20	(0.93)	—	(1.30)	(0.52)	(3.55)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	22.51	21.20	6.54	5.01	3.59	2.25	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	61.69	58.62	23.22	11.15	12.75	7.15
People
People	Employees	—	—	—	53	62	116	181	186	166	156
	Revenue/emp, $m	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income, $m
Income, $m	Revenue	—	—	—	—	—	—	—	—	—	—
	Gross margin, %	—	—	—	—	—	—	—	—	—	—
	EBT	—	—	(13)	(20)	(60)	(72)	(91)	(118)	(154)	(290)
	EBT margin, %	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	Net income	—	0	(13)	(20)	(60)	(72)	(92)	(118)	(155)	(288)
	Depreciation	—	—	0	0	0	0	0	0	0	0
Per share, $
Per share, $	Revenue	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	Earnings	—	—	(0.40)	(2.62)	(3.55)	(1.79)	(2.16)	(2.32)	(2.30)	(3.08)
	Cash flow	—	—	(0.30)	(2.38)	(2.44)	(1.69)	(2.48)	(1.91)	(1.77)	(1.68)
	Capex	—	—	0.00	(0.02)	(0.01)	(0.01)	(0.01)	0.00	0.00	0.00
	Free cash flow	—	—	(0.30)	(2.40)	(2.44)	(1.70)	(2.50)	(1.91)	(1.77)	(1.68)
	Book value	—	—	(0.43)	(4.06)	11.57	7.11	4.27	4.42	2.29	(0.57)
	Shares, m	—	—	33	7	17	40	42	51	67	94
Valuation, ×
Valuation, ×	P/E	—	—	—	—	—	—	—	—	—	—
	P/S	—	—	—	—	—	—	—	—	—	—
	P/B	—	—	—	—	—	—	—	—	—	—
	EV/Sales	—	—	—	—	—	—	—	—	—	—
	EV/FCF	—	—	—	—	—	—	—	—	—	—
Cash, $m
Cash, $m	Operating cash flow	—	—	(10)	(18)	(41)	(68)	(105)	(97)	(119)	(157)
	Capex	—	—	0	0	0	0	(1)	0	—	—
	Free cash flow	—	—	(10)	(18)	(42)	(68)	(106)	(97)	(119)	(157)
Balance, $m
Balance, $m	Working capital	—	—	24	8	196	280	176	242	167	(56)
	Total debt	—	—	—	21	—	1	0	29	30	32
	Net debt	—	—	(23)	(4)	(190)	(272)	(143)	(192)	(135)	(118)
	Shareholders’ equity	—	—	(14)	(30)	197	284	181	226	155	(53)
Returns, %
Returns, %	ROA	—	—	(100.20)	(66.74)	(51.16)	(28.45)	(36.73)	(50.06)	(63.36)	(135.78)
	ROIC	—	—	0.00	0.00	(517.66)	(417.98)	(180.08)	(252.71)	(574.41)	0.00
	ROE	—	—	59.07	87.64	(72.62)	(29.83)	(39.30)	(58.21)	(81.55)	(565.28)

Negative figures in brackets.

All 10 years →

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
SGRY Surgery Partners, Inc.	$1.8B	— (loss-making)	— (loss-making)	+2.75% (above 0%: growing)	n/m	−60.63% (below 0%: shrinking)	22.41%	12.78%	Compare
ASTH Astrana Health, Inc.	$1.8B	45.4×	29.7×	+48.52% (above 0%: growing)	+110.53% (above 0%: growing)	−67.74% (below 0%: shrinking)	10.70%	3.53%	Compare
SNDA Sonida Senior Living, Inc.	$1.7B	— (loss-making)	— (loss-making)	+122.02% (above 0%: growing)	n/m	−291.70% (below 0%: shrinking)	34.97%	(2.63%)	Compare
CMPS COMPASS Pathways PLC Sponsored ADR	$1.6B	— (loss-making)	—	—	n/m	−4.18% (below 0%: shrinking)	—	0.00%
ARDT Ardent Health, Inc.	$1.6B	20.5×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
AGL Agilon Health, Inc.	$1.4B	— (loss-making)	— (loss-making)	+7.15% (above 0%: growing)	n/m	−50.19% (below 0%: shrinking)	7.17%	0.79%	Compare
HCSG Healthcare Services Group, Inc.	$1.4B	11.9×	19.2×	+2.69% (above 0%: growing)	n/m	−26.02% (below 0%: shrinking)	15.89%	4.72%	Compare
PNTG The Pennant Group, Inc.	$1.4B	42.3×	26.9×	+35.76% (above 0%: growing)	+23.81% (above 0%: growing)	−50.94% (below 0%: shrinking)	14.07%	5.77%	Compare
NUTX Nutex Health Inc.	$1.4B	7.9×	6.3×	−13.62% (below 0%: shrinking)	n/m	+19.44% (above 0%: growing)	67.04%	57.75%	Compare
Median of peers	$1.5B	20.5×	19.2×	+4.95%	+23.81%	−50.56%	19.15%	4.12%

All 55 Medical Care Facilities stocks →

COMPASS Pathways PLC Sponsored ADR (CMPS) key facts

COMPASS Pathways PLC Sponsored ADR (CMPS) is a Medical Care Facilities company in the Healthcare sector, traded in the US as an ADR.
As of October 9, 2026, CMPS traded at $12.00, a market capitalization of $1.6 billion.
Return on equity was −565.3% and debt-to-equity 0.60.

Source: company filings (standardised) and stockrow calculations.